Sarepta Therapeutics Inc.

NASDAQ: SRPT · Real-Time Price · USD
21.82
1.52 (7.49%)
At close: Aug 15, 2025, 3:59 PM
21.86
0.16%
After-hours: Aug 15, 2025, 05:49 PM EDT

Sarepta Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.1B 428.43M 966.78M 2.12B
Short-Term Investments
251.78M 1.25B 1.02B n/a
Long-Term Investments
133.16M 6.53M 31.32M 34.89M
Other Long-Term Assets
241.01M 291.99M 286.62M 143.28M
Receivables
649.73M 439.71M 259.7M 171.64M
Inventory
749.96M 322.86M 203.97M 186.21M
Other Current Assets
9.21M 110.36M 78.49M 100.07M
Total Current Assets
3.07B 2.58B 2.56B 2.6B
Property-Plant & Equipment
488.65M 357.11M 244.99M 236.69M
Goodwill & Intangibles
26.89M 29.62M 7.58M 14.24M
Total Long-Term Assets
889.71M 685.25M 570.5M 543.88M
Total Assets
3.96B 3.26B 3.13B 3.15B
Account Payables
214.44M 164.92M 95.88M 76.74M
Deferred Revenue
130.26M 50.42M 89.24M 89.24M
Short-Term Debt
n/a 105.48M n/a n/a
Other Current Liabilities
278.48M 222.5M 340.53M 125.5M
Total Current Liabilities
731.68M 653.66M 619.6M 452.73M
Long-Term Debt
1.14B 1.13B 1.54B 1.1B
Other Long-Term Liabilities
49.15M 41.1M 36.94M 54.6M
Total Long-Term Liabilities
1.7B 1.75B 2.12B 1.77B
Total Liabilities
2.44B 2.41B 2.74B 2.22B
Total Debt
1.34B 1.4B 1.62B 1.14B
Common Stock
10K 9K 9K 9K
Retained Earnings
-4.21B -4.45B -3.91B -3.21B
Comprehensive Income
-218K 918K -1.66M -20K
Shareholders Equity
1.53B 859.34M 384.95M 928.01M
Total Investments
384.94M 1.25B 1.05B 34.89M